FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称LEMBOREXANT
异名/同义词(1R,2S)-2-(((2,4-DIMETHYLPYRIMIDIN-5-YL)OXY)METHYL)-2-(3-FLUOROPHENYL)-N-(5-FLUOROPYRIDIN-2-YL)CYCLOPROPANECARBOXAMIDE
(1R,2S)-2-((2,4-DIMETHYLPYRIMIDIN-5-YL)OXYMETHYL)-2-(3-FLUOROPHENYL)-N-(5-FLUOROPYRIDIN-2-YL)CYCLOPROPANE-1-CARBOXAMIDE
CYCLOPROPANECARBOXAMIDE, 2-(((2,4-DIMETHYL-5-PYRIMIDINYL)OXY)METHYL)-2-(3-FLUOROPHENYL)-N-(5-FLUORO-2-PYRIDINYL)-, (1R,2S)-
DAYVIGO
E2006
E-2006
LEMBOREXANT
LEMBOREXANT [INN]
LEMBOREXANT [JAN]
LEMBOREXANT [MI]
LEMBOREXANT [ORANGE BOOK]
LEMBOREXANT [USAN]
LEMBOREXANT [WHO-DD]
CAS登记号1369764-02-2
物质唯一标识(Unique Ingredient Identifier)0K5743G68X
分子式C22H20F2N4O2
国际化合物标识(International Chemical Identifier,InChI)MUGXRYIUWFITCP-PGRDOPGGSA-N
SMILES[C@@H]1([C@@](C1)(c2cc(ccc2)F)COc3c(nc(nc3)C)C)C(=O)Nc4ccc(cn4)F
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型INGREDIENT SUBSTANCE / chemical
关联数据
扩展资源
©2006-2024 Drugfuture->FDA Global Substance Registration System